Rational Design of High‐Performance Keratin‐Based Hemostatic Agents

Abstract Keratins are considered ideal candidates as hemostatic agents, but the development lags far behind their potentials due to the poorly understood hemostatic mechanism and structure–function relations, owing to the composition complexity in protein extracts. Here, it is shown that by using a recombinant synthesis approach, individual types of keratins can be expressed and used for mechanism investigation and further high‐performance keratin hemostatic agent design. In the comparative evaluation of full‐length, rod‐domain, and helical segment keratins, the α ‐helical contents in the sequences are identified to be directly proportional to keratins’ hemostatic activities, and Tyr, Phe, and Gln residues at the N‐termini of α ‐helices in keratins are crucial in fibrinopeptide release and fibrin polymerization. A feasible route to significantly enhance the hemostatic efficiency of helical keratins by mutating Cys to Ser in the sequences for enhanced water wettability through soluble expression is then further presented. These results provide a rational strategy to design high‐efficiency keratin hemostatic agents with superior performance over clinically used gelatin sponge in multiple animal models.